Ying Yuan

Ying Yuan

Auto-generated profile, based on publicly available information

Ying Yuan

Department of Geriatrics, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2017 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
YYYing Yuan
Ying Yuan
HQHong Qiu
Hong Qiu
XHXiaoying Hu
Xiaoying Hu
TLTong Luo
Tong Luo
XGXiaojin Gao
Xiaojin Gao
RGRunlin Gao
Runlin Gao
Background: Contrast‐induced acute kidney injury (CI‐AKI) is one of the most serious complications in patients who undergo percutaneous coronary intervention (PCI), especially in those with acute coronary syndrome. It has been shown that inflammation may play an important role in the pathophysiology of CI‐AKI.Hypothesis: Inflammatory factors may play a predominant role in the prediction of CI‐AKI in patients who undergo emergency PCI.Methods: Patients who underwent emergency PCI from 2013 to 2015 were consecutively enrolled and were divided into CI‐AKI and non–CI‐AKI groups. Logistic analysis was used to identify the risk factors of CI‐AKI. Receiver operator characteristic curve analysis was performed to evaluate the area under the curve (AUC) and to establish the optimal cutoff.Results: A total of 1061 patients were included, and the CI‐AKI rate was 5.47% (58/1061). Logistic analysis showed that the white blood cell (WBC) count (odds ratio [OR]: 1.103, 95% confidence interval [CI]: 1.018‐1.195, P = 0.016), neutrophil (N) count (OR: 1.134, 95% CI: 1.045‐1.232, P = 0.003), neutrophil to lymphocyte ratio (NLR) (OR: 1.105, 95% CI: 1.044‐1.169, P = 0.001), C‐reactive protein (CRP) level (OR: 1.006, 95% CI: 1.001‐1.011, P = 0.020), high‐sensitivity C‐reactive protein (hs‐CRP) level (OR: 1.099, 95% CI: 1.020‐1.184, P = 0.013), and big endothelin‐1 (ET‐1) level (OR: 4.030, 95% CI: 1.989‐8.165, P < 0.001) were all significant predictors for CI‐AKI, as was the left ventricular ejection fraction and diuretic administration. The AUC of the big ET‐1 level was the highest (0.793, 95% CI: 0.733‐0.853), followed by the NLR (0.708, 95% CI: 0.641‐0.774), hs‐CRP level (0.705, 95% CI: 0.627‐0.782), CRP level (0.684, 95% CI: 0.607‐0.761), N count (0.655, 95% CI: 0.584‐0.726), WBC count (0.620, 95% CI: 0.544‐0.695), and erythrocyte sedimentation rate (0.611, 95% CI: 0.527‐0.695).Conclusions: The WBC count, N count, NLR, CRP level, hs‐CRP level, and big ET‐1 level are all associated with an increased risk of CI‐AKI, and among which, the big ET‐1 level, NLR, and the hs‐CRP level might have high predictive value for CI‐AKI after an emergency PCI.

4 September 2023 in ESC Heart Failure
Verified
Journal Article
Open access
YYYing Yuan
Ying Yuan
MLMenghui Liu
Menghui Liu
SZShaozhao Zhang
Shaozhao Zhang
YLYifen Lin
Yifen Lin
YHYiquan Huang
Yiquan Huang
LXLiao Xin-xue
Liao Xin-xue
Aims: This study aimed to assess the effect of blood pressure (BP) index, in terms of level and variability, on the progression of cardiovascular and renal diseases in patients with both heart failure (HF) and chronic kidney disease (CKD). Methods and results: The study involved patients with HF and CKD from the database of the Chronic Renal Insufficiency Cohort (CRIC) study. The study endpoint includes the following: (i) primary endpoint, including cardiovascular disease (CVD) events, renal events, and all-cause death; (ii) CVD events; (iii) renal events; and (iv) all-cause death. Among 3939 participants in the CRIC study, a total of 382 patients were included. The duration of the follow-up was 6.3 ± 2.7 years, the age was 60.2 ± 8.9 years, and 57.6% were male. BP index included 20 indicators in relation to BP level and variability, 4 of which were analysed including baseline systolic BP (SBP), standard deviation of SBP, coefficient of variation of diastolic BP (DBP CV), and average real variability of pulse pressure. In the Cox regression analysis after adjustment, baseline SBP was significant for the risk of primary endpoint [hazard ratio (HR) 1.22, 95% confidence interval (CI) 1.03–1.44, P = 0.02] and renal events (HR 1.54, 95% CI 1.22–1.95, P < 0.001), and DBP CV was significant for the risk of primary endpoint (HR 1.03, 95% CI 1.01–1.06, P = 0.02) and CVD events (HR 1.04, 95% CI 1.02–1.07, P < 0.01). The result of the forest plot depicted that baseline SBP had a linear association with the risk of CVD and renal events (P = 0.04 and 0.001, respectively) and DBP CV with CVD events (P = 0.02). As the restricted cubic spline models displayed, DBP CV featured a J- or L-curved association with the primary endpoint, renal events, and all-cause death (P for nonlinearity = 0.01, <0.001, and 0.01, respectively). Conclusions: The baseline SBP and DBP CV may remain significant for clinical outcomes in patients with both HF and CKD. The increase in baseline SBP is associated with a higher risk of primary endpoint, CVD events, and renal events, and the increase in DBP CV with a higher risk of CVD events. Concerning nonlinear association, DBP CV features a J- or L-curved relationship with the primary endpoint, renal events, and all-cause death, with a higher risk at both low and high values. Trial registration: https://www.clinicaltrials.gov; unique identifier: NCT00304148.

1 November 2025 in Clinical Biochemistry
Verified
Journal Article
Closed access
LLLiubing Li
Liubing Li
YYYing Yuan
Ying Yuan
SYSiting Yi
Siting Yi
TDTangdan Ding
Tangdan Ding
HZHongji Zhu
Hongji Zhu
RWRuizhi Wang
Ruizhi Wang